US tissue customers of BTS co-operate with FDA investigation
This article was originally published in Clinica
Executive Summary
Five US tissue processors sold cadaverous bone, skin and tendons recovered by Biomedical Tissue Services, a New Jersey company now under investigation by US FDA for failing to follow its rules for screening donors for certain infectious diseases, the agency disclosed this week.